Identified potential biomarkers may predict primary nonresponse to infliximab in patients with ulcerative colitis

• Main Authors: Jixiang Zhang (Author), Xiaohan Wu (Author), Shuchun Wei (Author), Chuan Liu (Author), Xiaoli Wang (Author), Weiguo Dong (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Primary nonresponse to infliximab in patients with ulcerative colitis (UC) is common. However, there are currently no effective biomarkers for this prediction. This study aimed to identify potential predictors for precision anti-tumor necrosis factor-alpha treatment in patients with UC. Four GPL570...